36 related articles for article (PubMed ID: 10774480)
1. Changing paradigm of breast cancer.
Gopinath KS
Indian J Surg Oncol; 2011 Jun; 2(2):75. PubMed ID: 22693398
[No Abstract] [Full Text] [Related]
2. Impact of sentinel lymph node biopsy in newly diagnosed invasive breast cancer patients with suspicious node: a comparative accuracy survey of fine-needle aspiration biopsy versus core-needle biopsy.
Bhandari A; Xia E; Wang Y; Sindan N; Kc R; Guan Y; Lin YL; Wang X; Zhang X; Wang O
Am J Transl Res; 2018; 10(6):1860-1873. PubMed ID: 30018726
[TBL] [Abstract][Full Text] [Related]
3. Imaging methods for the local lymphatic system of the axilla in early breast cancer in patients qualified for sentinel lymph node biopsy.
Nowikiewicz T; Kurylcio A; Polkowski W; Zegarski W
Prz Menopauzalny; 2016 Mar; 15(1):52-5. PubMed ID: 27095960
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in breast cancer: a work in progress.
Chatterjee A; Serniak N; Czerniecki BJ
Cancer J; 2015; 21(1):7-10. PubMed ID: 25611773
[TBL] [Abstract][Full Text] [Related]
5. Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection.
Takamaru T; Kutomi G; Satomi F; Shima H; Ohno K; Kameshima H; Suzuki Y; Ohmura T; Takamaru H; Nojima M; Mori M; Hirata K
Exp Ther Med; 2014 Feb; 7(2):456-460. PubMed ID: 24396425
[TBL] [Abstract][Full Text] [Related]
6. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.
Pesek S; Ashikaga T; Krag LE; Krag D
World J Surg; 2012 Sep; 36(9):2239-51. PubMed ID: 22569745
[TBL] [Abstract][Full Text] [Related]
7. Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeons.
Mansfield L; Sosa I; Dionello R; Subramanian A; Devalia H; Mokbel K
Int Semin Surg Oncol; 2007 Feb; 4():4. PubMed ID: 17300717
[TBL] [Abstract][Full Text] [Related]
8. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
9. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.
Cserni G
J Clin Pathol; 2002 Dec; 55(12):926-31. PubMed ID: 12461060
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer.
Cserni G; Rajtár M; Boross G; Sinkó M; Svébis M; Baltás B
World J Surg; 2002 May; 26(5):592-7. PubMed ID: 12098052
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.
Cantin J; Scarth H; Levine M; Hugi M;
CMAJ; 2001 Jul; 165(2):166-73. PubMed ID: 11501455
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry.
Torrenga H; Rahusen FD; Meijer S; Borgstein PJ; van Diest PJ
J Clin Pathol; 2001 Jul; 54(7):550-2. PubMed ID: 11429428
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
14. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
15. Learning curves and certification for breast cancer lymphatic mapping.
Bass SS; Cox CE; Reintgen DS
Surg Oncol Clin N Am; 1999 Jul; 8(3):497-509. PubMed ID: 10448692
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. [Sentinel lymph node biopsy and axillary lymph node dissection].
Noguchi M; Tsugawa K; Miwa K; Taniya T
Gan To Kagaku Ryoho; 2000 Jul; 27(7):961-6. PubMed ID: 10925679
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer.
Cox CE; Bass SS; McCann CR; Ku NN; Berman C; Durand K; Bolano M; Wang J; Peltz E; Cox S; Salud C; Reintgen DS; Lyman GH
Annu Rev Med; 2000; 51():525-42. PubMed ID: 10774480
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
